Cerenome (PSTV) Assets Average (2011 - 2026)
Plus Therapeutics (PSTV) posted quarterly Assets Average of $18.1 million for Q1 2026, up 93.92% year-over-year from $9.3 million in Q1 2025, and up 3.56% quarter-over-quarter from $17.5 million in Q4 2025.
Cerenome (PSTV) Assets Average (2011 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has reported Assets Average for 16 consecutive years, with $18.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average rose 93.92% year-over-year to $18.1 million; the TTM figure through Mar 2026 stood at $18.1 million (up 93.92% YoY), while the FY2025 annual figure was $11.5 million, up 27.4% from the prior year.
- Assets Average climbed to $18.1 million in Q1 2026 per PSTV's latest filing, from $17.5 million in the prior quarter.
- Across five years, Assets Average topped out at $23.5 million in Q4 2022 and bottomed at $6.8 million in Q4 2024.
- Historically, Assets Average has averaged $15.1 million across 5 years, with a median of $14.5 million in 2025.
- Annual changes were most pronounced in 2024 — Assets Average sank 56.94% — and 2025, when it jumped 157.11%.
- Plus Therapeutics' Assets Average stood at $23.5 million in 2022, then plunged by 47.49% to $12.3 million in 2023, then tumbled by 44.82% to $6.8 million in 2024, then soared by 157.11% to $17.5 million in 2025, then climbed by 3.56% to $18.1 million in 2026.
- Business Quant data shows PSTV's Assets Average at $18.1 million in Q1 2026, $17.5 million in Q4 2025, and $14.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - | 16.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.12 Mn |
| Dec 31, 2025 | 17.50 Mn |
| Sep 30, 2025 | 14.51 Mn |
| Jun 30, 2025 | 11.20 Mn |
| Mar 31, 2025 | 9.34 Mn |
| Dec 31, 2024 | 6.81 Mn |
| Sep 30, 2024 | 9.10 Mn |
| Jun 30, 2024 | 8.42 Mn |
| Mar 31, 2024 | 8.50 Mn |
| Dec 31, 2023 | 12.33 Mn |
| Sep 30, 2023 | 13.74 Mn |
| Jun 30, 2023 | 14.92 Mn |
| Mar 31, 2023 | 19.75 Mn |
| Dec 31, 2022 | 23.49 Mn |
| Sep 30, 2022 | 22.19 Mn |
| Jun 30, 2022 | 22.89 Mn |
| Mar 31, 2022 | 23.25 Mn |
| Dec 31, 2021 | 23.37 Mn |
| Sep 30, 2021 | 22.79 Mn |
| Jun 30, 2021 | 19.59 Mn |